Literature DB >> 22339491

Elevated levels of serum chemerin in patients with obstructive sleep apnea syndrome.

Xuewei Feng1, Peng Li, Chuming Zhou, Xi Jia, Jian Kang.   

Abstract

CONTEXT: Chemerin is implicated to be correlated with obesity and inflammation.
OBJECTIVE: This study aims to investigate whether serum chemerin is associated with the presence of obstructive sleep apnea syndrome (OSAS).
METHODS: A total of 132 patients with OSAS and 108 healthy subjects were enrolled in this study.
RESULTS: Serum chemerin levels were significantly elevated in OSAS patients (120.93 ± 25.84 µg/L vs. 107.51 ± 20.41 µg/L). Multivariable logistic regression analysis revealed that serum chemerin levels were an independent determinant of the presence of OSAS (OR 1.030, 95% CI 1.016-1.045; p < 0.001). Serum chemerin levels in severe OSAS patients were significantly higher compared with those in mild and moderate OSAS patients (p = 0.015 and p = 0.020, respectively). Spearman correlation analysis indicated that serum chemerin levels were correlated with the severity of OSAS (r = 0.210, p = 0.016). Serum chemerin were positively correlated with waist circumference (r = 0.164, p = 0.008), body mass index (r = 0.158, p = 0.014), systolic blood pressure (r = 0.135, p = 0.037), homeostasis model assessment of insulin resistance (r = 0.140, p = 0.031), C-reactive protein (r = 0.202, p = 0.002), and apnea-hypopnea index (r = 0.152, p = 0.022).
CONCLUSION: Elevated serum chemerin levels could be an independent predicting marker of the presence and severity of OSAS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339491     DOI: 10.3109/1354750X.2012.658864

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  14 in total

Review 1.  Biomarkers associated with obstructive sleep apnea: A scoping review.

Authors:  Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal
Journal:  Sleep Med Rev       Date:  2014-11-28       Impact factor: 11.609

2.  Impact of OSA on biological markers in morbid obesity and metabolic syndrome.

Authors:  Neus Salord; Mercè Gasa; Mercedes Mayos; Ana Maria Fortuna-Gutierrez; Josep Maria Montserrat; Manuel Sánchez-de-la-Torre; Antonia Barceló; Ferran Barbé; Núria Vilarrasa; Carmen Monasterio
Journal:  J Clin Sleep Med       Date:  2014-03-15       Impact factor: 4.062

3.  An orthodontic-orthognathic patient with obstructive sleep apnea treated with Le Fort I osteotomy advancement and alar cinch suture combined with a muco-musculo-periosteal V-Y closure to minimize nose deformity.

Authors:  Takayoshi Ishida; Asuka Manabe; Shin-Sheng Yang; Kenzo Watakabe; Yasunori Abe; Takashi Ono
Journal:  Angle Orthod       Date:  2019-01-30       Impact factor: 2.079

Review 4.  Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

5.  The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension.

Authors:  Stephanie W Watts; Emma S Darios; Adam E Mullick; Hannah Garver; Thomas L Saunders; Elizabeth D Hughes; Wanda E Filipiak; Michael G Zeidler; Nichole McMullen; Christopher J Sinal; Ramya K Kumar; David J Ferland; Gregory D Fink
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

6.  Serum S100A12 levels are associated with the presence and severity of obstructive sleep apnea syndrome in male patients.

Authors:  You-kui Shi; Jing-xia Chen; Yan Huang; Ai-ying Li
Journal:  Sleep Breath       Date:  2013-07-19       Impact factor: 2.816

7.  Chemerin connects fat to arterial contraction.

Authors:  Stephanie W Watts; Anne M Dorrance; Mark E Penfold; Jillian L Rourke; Christopher J Sinal; Bridget Seitz; Timothy J Sullivan; Trevor T Charvat; Janice M Thompson; Robert Burnett; Gregory D Fink
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

8.  Different blood pressure responses in hypertensive rats following chemerin mRNA inhibition in dietary high fat compared to dietary high-salt conditions.

Authors:  David J Ferland; Emma D Flood; Hannah Garver; Steve T Yeh; Stanley Riney; Adam E Mullick; Gregory D Fink; Stephanie W Watts
Journal:  Physiol Genomics       Date:  2019-10-07       Impact factor: 3.107

9.  Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma.

Authors:  Susanne Feder; Arne Kandulski; Doris Schacherer; Thomas S Weiss; Christa Buechler
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

10.  Association of Adipocytokines With Carotid Intima Media Thickness and Arterial Stiffness in Obstructive Sleep Apnea Patients.

Authors:  Fan Song; Juanjuan Zou; Zhiyuan Song; Huajun Xu; Yinjun Qian; Huaming Zhu; Suru Liu; Jian Guan; Jie Chen; Hongliang Yi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.